Source: Annual Congress 2008 - Imaging and measurement techniques in the evaluation of pulmonary embolism, COPD and pleural diseases
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
G. Ak, M. Metintas, H. Yildirim, S. Arslan, S. Erginel, F. Alatas, S. Metintas (Eskisehir, Turkey). The importance of radiological findings to distinguish benign and malignant pleural diseases. Eur Respir J 2008; 32: Suppl. 52, 4299

Member's Comments

No comment yet.

Related content which might interest you: Radiologic manifestations of primary pleural tumors Source: Annual Congress 2010 - Vascular and solitary lesions Year: 2010 The use of immunocytochemistry to diagnose the etiology of malignant pleural effusion. Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management Year: 2018 Diagnostic problems in benign and malignant pleural effusions Source: Annual Congress 2007 - PG16 - Management of pleural problems in your practice today Year: 2007 Pathological diagnosis of malignant pleural mesothelioma Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases Year: 2020 The radiologic evidance in distinguishing the pleural mesothelioma from the pleural metastatic adenocarcinoma Source: Eur Respir J 2006; 28: Suppl. 50, 93s Year: 2006 Epidemiology, etiology, prognosis and presentation of malignant pleural mesothelioma Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases Year: 2020 A rare case of malignant pleural mesothelioma presenting with multiple metastatic pulmonary nodules Source: Annual Congress 2011 - Pleural and mediastinal malignancies: management and rare clinical cases Year: 2011 The role of 99m-Tc-Depreotide scintigraphy in discriminating between malignant and benign pulmonary nodules Source: Eur Respir J 2005; 26: Suppl. 49, 492s Year: 2005 Sonographic echogenic swirling pattern in patients with malignancies: a useful diagnostic predictor for malignant pleural effusions Source: Annual Congress 2008 - Imaging and measurement techniques in the evaluation of pulmonary embolism, COPD and pleural diseases Year: 2008 Prognostic significance of pretreatment clinical and laboratory characteristics in patients with diffuse malignant pleural mesothelioma Source: Eur Respir J 2006; 28: Suppl. 50, 784s Year: 2006 A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions Source: Eur Respir J 2013; 41: 18-24 Year: 2013 The management of benign non-infective pleural effusions Source: Eur Respir Rev 2016; 25: 303-316 Year: 2016 A case report: surprising diagnosis of malignant mesothelioma in a patient with malignant pleural effusion, mediastinal lymphoma and intestinal carcinoma in situ Source: Eur Respir J 2004; 24: Suppl. 48, 527s Year: 2004 Dealing with diagnosis of benign and malignant pleural effusions Source: Annual Congress 2010 - PG5 Postgraduate Course: Interventional thoracoscopy Year: 2010 ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma Source: Guideline 2020 Year: 2020 ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma Source: Eur Respir J, 55 (6) 1900953; 10.1183/13993003.00953-2019 Year: 2020 Comparison of telomerase activity in malignant and benign pleural effusions Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura Year: 2011 Diagnosis and staging of malignant pleural mesothelioma Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases Year: 2020 Outcomes of cytology positive malignant pleural effusions; do certain malignancies predispose patients to trapped lung? Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice? Year: 2019